Delivery Order SPE2DB25D3017-SPE2DB25FVJPK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens, with a contract ceiling value of $9,796.98 and an ultimate completion date of August 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,178.81 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens (0.5 mL), a prescription diabetes medication. The contract was competitively awarded without set-aside designation on September 3, 2025, with an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,949.85 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.59 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication used within military and federal healthcare systems. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen, headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, reflects a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed the delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a $1,634.52 delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed price, non-set-aside contract with a completion date of May 22, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,292.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,108.74 to supply Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award where the pharmaceutical distributor will fulfill the delivery order from its facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major healthcare solutions provider and pharmaceutical distributor serving as a...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJPKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,359.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml), a diabetes medication. The contract was executed as a firm fixed price delivery order on June 25, 2025, with an ultimate completion date of June 26, 2025, and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad spectrum of pharmaceutical products, medical devices, vaccines, and healthcare commodities to support military and veteran healthcare systems. The company's federal contract portfolio demonstrates consistent success in competitively awarded contracts with the DLA, covering diverse therapeutic domains including specialty medications, diabetes treatments, neurological agents, pain management pharmaceuticals, and medical supplies. The DLA Troop Support Medical contract enables AmerisourceBergen to serve multiple government healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a strategic partner in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 6/25/25 |